{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:04:42Z","timestamp":1777374282574,"version":"3.51.4"},"reference-count":117,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro (FAPERJ, Rio de Janeiro, Brazil),","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Analytical Chemistry"],"published-print":{"date-parts":[[2022,11,17]]},"DOI":"10.1080\/10408347.2021.1920364","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T19:41:48Z","timestamp":1621798908000},"page":"1846-1862","source":"Crossref","is-referenced-by-count":9,"title":["Lopinavir\/Ritonavir: A Review of Analytical Methodologies for the Drug Substances, Pharmaceutical Formulations and Biological Matrices"],"prefix":"10.1080","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-8672","authenticated-orcid":false,"given":"Carolina Trajano","family":"Velozo","sequence":"first","affiliation":[{"name":"Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-5729","authenticated-orcid":false,"given":"Lucio Mendes","family":"Cabral","sequence":"additional","affiliation":[{"name":"Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6706-9585","authenticated-orcid":false,"given":"Eduardo Costa","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1589-0846","authenticated-orcid":false,"given":"Val\u00e9ria Pereira","family":"de Sousa","sequence":"additional","affiliation":[{"name":"Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,5,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1992.8.153"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804303381808"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2165\/11204950-000000000-00000"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.6.9.1573"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.13.2363"},{"key":"CIT0006","unstructured":"Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/inline-files\/AdultandAdolescentGL.pdf (accessed Dec 12, 2020)."},{"key":"CIT0007","unstructured":"Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/inline-files\/pediatricguidelines.pdf (accessed Dec 12, 2020)."},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2020.11.005"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.12.005"},{"key":"CIT0010","volume-title":"Lopinavir\/Ritonavir: A Rapid Review of Effectiveness in COVID-19. The Centre for Evidence-Based Medicine","author":"Doward J."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104859"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32013-4"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"CIT0014","unstructured":"Harris, M.; Bagozzi, D. WHO Discontinues Hydroxychloroquine and Lopinavir\/Ritonavir Treatment Arms for COVID-19. https:\/\/www.who.int\/news-room\/detail\/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19 (accessed Oct 20, 2020)."},{"key":"CIT0015","volume-title":"United States Pharmacopeia","year":"2020","edition":"43"},{"key":"CIT0016","volume-title":"European Pharmacopeia, 10th ed.","year":"2019"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.06.004"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1039\/c1ay05140g"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmu097"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmx110"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2013.11.029"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1590\/S1984-82502014000200009"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.07.022"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.08.007"},{"key":"CIT0025","volume-title":"International Pharmacopeia","year":"2019","edition":"9"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.09.015"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.810"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2011.01.039"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.1407-14"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1002\/mrc"},{"key":"CIT0031","unstructured":"International Conference on Harmonization. Impurities in New Drug Substances Q3A(R2). IFPMA, Geneva, Switzerland, 2006."},{"key":"CIT0032","unstructured":"International Conference on Harmonization. Impurities in New Drug Products Q3B(R2). IFPMA, Geneva, Switzerland, 2003."},{"key":"CIT0033","unstructured":"International Conference on Harmonization. Stability Testing of New Drug Substances and Products Q1A (R2). IFPMA, Geneva, Switzerland, 2003."},{"key":"CIT0034","unstructured":"International Conference on Harmonization. Stability Testing: Photostability Testing of New Drug Substances and Products Q1B. IFPMA, Geneva, Switzerland, 1996."},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2017.09.012"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1002\/jps"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2017.10.025"},{"key":"CIT0038","unstructured":"International Conference on Harmonization. Bioanalytical Method Validation M10. IFPMA, Geneva, Switzerland, 2019."},{"key":"CIT0039","volume-title":"Farmacopeia Brasileira","year":"2019","edition":"6"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24492"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/c2014-1-02188-6"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.07.044"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.2174\/1568026619666190619115243"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.5958\/0973-9130.2017.00069.X"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1021\/jm970636"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.12.3218"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.01.014"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666090-00012"},{"key":"CIT0049","unstructured":"European Medicines Agency. Norvir. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/norvir#product-information-section (accessed Apr 5, 2021)."},{"key":"CIT0050","unstructured":"U.S. Food and Drugs Administration. Norvir. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/020659s072,022417s024,209512s007lbl.pdf (accessed Apr 5, 2021)."},{"key":"CIT0051","unstructured":"U.S. Food and Drugs Administration. Kaletra Medication Guide, 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021251s059,021906s054lbl.pdf#page=53 (acessed Apr 5, 2021)."},{"key":"CIT0052","unstructured":"European Mecicines Agency. Kaletra. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kaletra (accessed Apr 5, 2021)."},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2336"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1284"},{"key":"CIT0055","first-page":"1137","volume-title":"Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics","author":"Flexner C. W.","year":"2017"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1007\/82"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.10.003"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200060060-00009"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1016\/s2173-5085(10)70018-6"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-005X(08)76605-9"},{"key":"CIT0061","volume-title":"Update of Recommendations on First- and Second-Line Antiretroviral Regimens (WHO\/CDS\/HIV\/19.15).","year":"2019"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.03.034"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.05.016"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31042-4"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit132"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.03.021"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2017.03.009"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.639-648.2006"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2017.12.003"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199835040-00002"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1007\/BF02260156"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.6227\/jfda.2012200428"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1007\/BF02491201"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(95)00123-Z"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1002\/jps"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.02.010"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.07.068"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(02)01812-5"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1021\/ac970765y"},{"key":"CIT0080","unstructured":"Naegele, E. Making your LC Method Compatible with Mass Spectrometry: Technical Overview. https:\/\/www.agilent.com\/cs\/library\/technicaloverviews\/public\/5990\u20137413EN.pdf (accessed Jul 11, 2020)."},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2009.02.010"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.8b00246"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.200600451"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2005.06.035"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.07.031"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(02)00295-7"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2005.08.090"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.11.037"},{"key":"CIT0089","unstructured":"Phenomenex Inc. Reversed Phase HPLC Solutions for Proteins and Peptides. https:\/\/phenomenex.blob.core.windows.net\/documents\/0b443e75-6169-4b6a-b1a3-14d0bf63d914.pdf (accessed Jul 11, 2020)."},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(02)00357-6"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2007.05.020"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(99)00573-3"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00208-5"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2004.10.005"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(02)00465-8"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2009.08.010"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2014.06.034"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(02)00026-1"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.08.016"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1365\/s10337-006-0785-y"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2014.11.006"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1365\/s10337-005-0670-0"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1021\/op990202j"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1002\/9781118971147.ch24"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1021\/cr300095f"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201401143"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1021\/op900341a"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5186.90894"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2015.05.001"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-6395(07)00012-8"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201000398"},{"key":"CIT0112","unstructured":"DrugBank [online]. https:\/\/go.drugbank.com\/ (accessed Jul 11, 2020)."},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.40.1.649"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00454-4"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(98)00220-5"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8719(99)00013-1"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2006.07.071"}],"container-title":["Critical Reviews in Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408347.2021.1920364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T10:04:13Z","timestamp":1667815453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408347.2021.1920364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,23]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11,17]]}},"alternative-id":["10.1080\/10408347.2021.1920364"],"URL":"https:\/\/doi.org\/10.1080\/10408347.2021.1920364","relation":{},"ISSN":["1040-8347","1547-6510"],"issn-type":[{"value":"1040-8347","type":"print"},{"value":"1547-6510","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,23]]}}}